SHAREHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2018

Stockholders' Equity Note [Abstract]

A summary of the Company's stock option activity, and related information, is as follows:

	Year ended December 31, 2018
	Amount			Weighted average exercise price		Weighted average remaining contractual term (years)

Outstanding at the beginning of the year		62,000		$	9.93		0.83
Granted		-
Forfeited		(60,000	)	$	10
Exercised		(2,000	)	$	7.97

Outstanding at the end of the year		-			-		-

Exercisable options at end of year		-			-		-

Options vested and expected to vest at end of year		-			-		-

Schedule of Restricted Shares Activity

A summary of the status of the entity's restricted shares as of December 31, 2018, and changes during the year ended December 31, 2018, is presented below:

Restricted shares	Shares			Weighted average grant date fair value

Non-vested at January 1, 2018		4,000		$	7.47

Granted		-
Vested		(4,000	)	$	7.47

Non-vested at December 31, 2018		-			-

Schedule of Equity-based Compensation Expense

The total equity-based compensation expense related to all of the Company's equity-based awards, recognized for the years ended December 31, 2018, 2017 and 2016, was comprised as follows:

	Year ended December 31,
	2018		2017		2016

General and administrative		-		15		60